Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
Go back to Ligand Reports Fourth Quarter and Full Year 2023 Financial Results| ALDEYRA THERAPEUT (NASDAQ: ALDX) | Delayed: 1.37 -0.01 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.38 | 52 Week High | $8.19 | |||
| Open | $1.40 | 52 Week Low | $3.39 | |||
| Day High | $1.40 | P/E | N/A | |||
| Day Low | $1.36 | EPS | $0.00 | |||
| Volume | 161,514 | |||||
| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 281.54 -3.16 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $284.70 | 52 Week High | $139.79 | |||
| Open | $285.63 | 52 Week Low | $82.07 | |||
| Day High | $285.64 | P/E | 654.74 | |||
| Day Low | $280.49 | EPS | $0.43 | |||
| Volume | 67,232 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 146.04 -1.11 (0.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.15 | 52 Week High | $65.46 | |||
| Open | $147.08 | 52 Week Low | $47.97 | |||
| Day High | $147.84 | P/E | 99.35 | |||
| Day Low | $145.74 | EPS | $1.47 | |||
| Volume | 3,697,144 | |||||
| (NASDAQ: TVTX) | Delayed: 62.60 -2.14 (3.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.74 | 52 Week High | $ | |||
| Open | $64.89 | 52 Week Low | $ | |||
| Day High | $64.89 | P/E | N/A | |||
| Day Low | $62.47 | EPS | $ | |||
| Volume | 436,841 | |||||
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 28.48 -0.88 (3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.36 | 52 Week High | $5.17 | |||
| Open | $29.57 | 52 Week Low | $0.94 | |||
| Day High | $29.68 | P/E | N/A | |||
| Day Low | $28.40 | EPS | $0.00 | |||
| Volume | 1,050,407 | |||||
| (NASDAQ: VRNA) | Delayed: 106.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.91 | 52 Week High | $ | |||
| Open | $106.91 | 52 Week Low | $ | |||
| Day High | $106.91 | P/E | N/A | |||
| Day Low | $106.91 | EPS | $ | |||
| Volume | 520,059 | |||||

